CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$1.72
-0.03 (-1.71%)
▼
5d:
-7.03%
30d:
-17.7%
90d:
-31.47%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
CLOV is down 6.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-05-15 with 19,408 OI. Call ratio: 100% View Scanner →
Strength: 8.3/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CLOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $1.72, which is considered oversold relative to its 30-day fair value range of $1.85 to $2.08. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.1) compared to its historical average (35.2). Remarkably, the market is currently pricing in an annual earnings decline of 18.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a downtrend. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.82 (+63.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLOV is in a downtrend. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.82 (+63.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.85 -
$2.08
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 63.8% below Wall St target ($2.82)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.85 -
$2.08
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$1.99
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.11
Wall Street Target
$2.82
(+63.8%)
Revenue Growth (YoY)
44.7%
Profit Margin
-4.5%
Valuation Discount vs History
-18.4% cheaper
PE vs Historical
19.1 vs 35.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.4%
(market-implied from PE analysis)
1-Year Target
$1.55
(-10%)
2-Year Target
$1.39
(-19%)
3-Year Target
$1.25
(-27%)
3-Yr Target (if PE normalizes)
(PE: 19→35)
$2.31
(+34%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 12.5%)
$2.86
(+67%)
Base:
(SPY PE: 19.1, Growth: 12.5%)
$2.45
(+42%)
Bear:
(PE: 16.2, Growth: 12.5%)
$2.08
(+21%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.1 to 35.2
Stabilization Target:
$3.17
(+84.2%)
PE Expansion Potential:
+84.2%
Share & Embed Analysis
Last updated: March 30, 2026 11:59 PM ET
Data refreshes hourly during market hours. Next update: 12:59 AM
Data refreshes hourly during market hours. Next update: 12:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$97 | 57 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$339 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$361 | 49 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$381 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$212 | 61 BUY |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
